PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10949253

Are public dose limits necessary?

P H Jensen
View original source ↗Export metadata ↓

Abstract

The distinction between practices and interventions in the System of Radiation Protection has created a lot of confusion in the population and amongst decision-makers, especially with regards to the concepts of dose limits and intervention levels. The experience gained after the Chernobyl accident indicated that many actions taken led to an unnecessarily large expenditure of national resources and many instances occurred of contradictory national responses. A major reason was the mixture of dose limits for the population, which apply only to exposures from practices, and intervention levels, which apply only to protective measures in de-facto exposure situations. The existing System of Radiation Protection is revisited and it is suggested that the System can be revised with no dose limits for the public without causing a lower degree of protection of the population. With the widespread use of source-related dose constraints and practical restrictions on the sources of public exposure from practices, generally applicable dose limits are rarely limiting in any practical situation, even if dose constraints might, at least in principle, fail to take adequate account of the exposures from other practices. Constraints can be expressed as operational protection quantities, e.g., nuclide-specific release rates, dose rate at the fence of a facility, or nuclide-specific surface contamination density in the environment. A revised System of Radiation Protection without public dose limits would not cause any reduced protection of the public compared to the existing System, and it has a potential for removing much of the confusion with regards to application of intervention/action levels. It would also have the potential for improving public perception of radiation protection and radiation risks as well as for saving vast resources in intervention situations for better application in general health care of the public.

Explore related subjects

HumansInternational AgenciesPublic HealthRadiation DosageRadiation ProtectionRisk AssessmentJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P H Jensen. 2000. Are public dose limits necessary?. https://doi.org/10.1097/00004032-200009000-00008

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗
PubMed2027

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗
PubMed2027

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗